Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT00891267
Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
60 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Metabolic Syndrome
Hypertension
Terminated
NCT00679484
Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24
400 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Chronic Heart Failure
High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level
Completed
NCT00676845
Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection
133 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Metabolic Syndrome
Hypertension
Completed
NCT00220233
Olmesartan as an add-on to Amlodipine in Hypertension
632 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00220220
Amlodipine as add-on to Olmesartan in Hypertension
429 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00185133
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
1,900 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Hypertension
Unknown status
NCT03777631
STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study
250 Enrollment(s)
24 Study location(s)
Interventional (Phase III)
Ischemic Stroke
Atrial Fibrillation Non-Rheumatic
Completed
NCT02848170
Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension
40 Enrollment(s)
0 Study location(s)
Interventional (Not Applicable)
Essential Hypertension